From: Prevalence of metabolic syndrome among patients with Schizophrenia in Palestine
Variable | With MS N(%) or Mean ± SD | Without MS N(%) or Mean ± SD | Unadjusted OR (95% CI) | Adjusted OR (95% CI) |
---|---|---|---|---|
Age (years) | 45.1 ± 10.4 | 39.5 ± 12.2 | 1.04 (1.02 –1.07) | 0.98 (0.93 – 1.03) |
Gender | ||||
Female | 38 (55.9%) | 30 (44.1%) | 2 (1.1 – 3.5) | 1.91 (0.64 – 5.69) |
Male | 71 (39%) | 111 (61%) | ||
Duration | ||||
< 10 years | 90 (42.3%) | 123 (57.7%) | 2.2 (1.3 – 3.8) | 1.94 (0.62 – 6.01) |
>10 years | 19 (51.4) | 18 (48.6%) | ||
Smoking | ||||
Yes | 55 (35.1%) | 98 (64.9%) | 2.2 (1.3 – 3.8) | 2.16 (0.82 – 5.69) |
No | 54 (55.7%) | 43 (44.3%) | ||
Marital status | ||||
Married | 53 (47.3%) | 59 (52.7%) | 0.76 (0.46 – 1.25) | – |
Single | 56 (40.6%) | 82 (59.4%) | ||
Education | ||||
< 12 years | 90 (42.3%) | 123 (57.7%) | 1.4 (0.7 – 2.9) | – |
>12 years | 19 (51.4%) | 18 (48.6%) | ||
Occupation | ||||
Employed | 12 (38.7%) | 19 (61.3%) | 0.8 (0.36 – 1.7) | – |
Unemployed | 97 (44.3%) | 122 (55.7%) | ||
Family history of DM | ||||
Yes | 52 (46.4%) | 60 (53.6%) | 1.2(0.75 – 2.04) | – |
No | 57 (41.3%) | 81 (57.7%) | ||
CPZeq (mg) | 432 ± 284.3 | 440.6 ± 269.7 | 1(0.9 – 1) | – |
Therapeutic Regimen | ||||
Monotherapy | 53 (42.7%) | 71 (57.3%) | 1.07(0.65 – 1.8) | – |
Combination | 56 (44.4%) | 70 (55.6%) | ||
Depot antipsychotic | ||||
Yes | 68 (49.3) | 70 (50.7%) | 1.7 (1.01 – 2.8) | 1.74 (0.73 – 4.14) |
No | 41 (36.6%) | 71 (63.4%) | ||
Olanzpine/Clozapine | ||||
Yes | 10 (33.3%) | 20 (66.7%) | 0.61 (0.3 – 1.4) | – |
No | 99 (45%) | 121 (55%) | ||
WC (cm) | 105.1 ± 13.2 | 92.3 ± 10.7 | 1.1 (1.07 – 1.1) | 1.09 (1.05 – 1.13) |
Systolic BP (mmHg) | 131.1 ± 12.9 | 118.9 ± 13.2 | 1.07 (1.05 – 1.1) | 1.11 (1.07 – 1.16) |
Diastolic BP (mmHg) | 78.4 ± 10.1 | 73.2 ± 10.9 | 1.05 (1.02 – 1.07) | 0.96 (0.92 – 1.01) |
TG (mg/dl) | 256.4 ± 224.6 | 144.3 ± 115.4 | 1 (1 – 1) | 1.01 (1.0 – 1.01) |
HDL (mg/dl) | 42.4 ± 11.8 | 46.2 ± 9.9 | 0.96 (0.94 – 0.99) | 0.95 (0.91 – 1.00) |
LDL (mg/dl) | 121.7 ± 36.8 | 112.1 ± 39.1 | 1 (1 – 1.01) | |
FPG (mg/dl) | 120.5 ± 64.5 | 83.3 ± 13.9 | 1.05 (1.03 – 1.07) | 1.06 (1.03 - 1.09) |